Tag: Chemotherapy
Salvage Therapy Does Not Up Survival for Progressive Myeloma
Deepening of response through salvage therapy not linked to improved progression-free, overall survival
Risk for Cardiovascular Disease Greater for Childhood Cancer Survivors
Exposure to ≥250 mg/m² doxorubicin-equivalent anthracycline chemo tied to risk for CVD, heart failure
Delay in Time to Chemo Impacts Survival in Breast Cancer
Time interval from diagnosis to surgery has largest impact on time from diagnosis to chemo initiation
Light Therapy May Prevent Oral Mucositis for Some in Cancer Tx
Laser, other light tx recommended for patients treated with HSCT; head and neck RT with, without chemo
High Response Seen for Chemo in Seniors With High-Risk AML
Complete response rate for patients treated with chemo was 69 percent; three-year OS was 21 percent
Chemoradiation Does Not Up Survival in Endometrial Cancer
Distant recurrence more common with chemoradiation versus chemotherapy in stage III, IVA disease
Chemoimmunotherapy Regimen Approved to Treat DLBCL
Polivy approved in combination with bendamustine, rituximab for diffuse large B-cell lymphoma
ASCO: Low-Dose Chemo Benefits Advanced Gastroesophageal Cancer
Elderly, frail receiving 60 percent of oxaliplatin/capecitabine dose have noninferior PFS, less toxicity
ASCO: Pembrolizumab Noninferior to Chemo in Advanced Gastric Cancer
For patients with PD-L1 combined positive score of ≥10, pembrolizumab prolongs overall survival
Octogenarians With Acute Myeloid Leukemia Have Poor Survival
Overall survival 1.5 months; survival improved for those receiving chemotherapy
